Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

"Fountain of Youth" Pill SeroVital®-hgh Steals Show at Washington, DC Women's Health Conference

Research Behind hGH Booster Had Experts at Annual Meeting Buzzing


News provided by

SeroVital

Mar 20, 2014, 03:13 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, March 20, 2014 /PRNewswire/ -- The Annual Meeting of the prestigious American Medical Women's Association (AMWA) in Washington, D.C. concluded Sunday, and while it was the venue for some of the most cutting-edge women's health research in the world, at this year's conference one of the main highlights was — believe it or not — a "Fountain of Youth" pill called SeroVital®-hgh (an oral human growth hormone [hGH] booster). This isn't the first time SeroVital was a surprise hit at a women's conference. Just a few months ago at The Academy of Women's Health's 2013 Annual Congress, SeroVital changed the attitude of many healthcare providers on the rising popularity of growth hormone therapy. Why? Because rather than introducing a synthetic form of hGH into the body through controversial injections, SeroVital raises hGH levels naturally by nourishing the pituitary, the gland that manufactures hGH.

So why is growth hormone such a hot topic at women's conferences? Because hGH is no longer just for professional athletes. In fact, everyone from soccer moms to Hollywood A-Listers have been visiting some of the most expensive clinics in the world for controversial hGH injections due to growth hormone's touted ability to reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.

"Human growth hormone is no longer solely the province of male athletes," says Gina Daines, spokesperson for SanMedica International™, SeroVital's distributor. "Research is revealing that growth hormone is a vital aspect of women's health that could affect everything from obesity to skin and aging to sex drive."

SeroVital began making waves in the research world when the results of the double-blind, placebo-controlled clinical trial on its highly specialized, key compound were presented for the first time at The Obesity Society's Annual Scientific Meeting in San Antonio, Texas. At this exclusive conference, a group of some of the most renowned research scientists in the world revealed that this tiny little pill was actually capable of increasing mean, serum (blood) growth hormone levels... by an astounding 682%.

Since then, SeroVital has been presented at scientific conferences around the world: The American Congress of Obstetricians and Gynecologists 61st Annual Clinical Meeting in New Orleans, Louisiana; Sleep 2013, the 27th Annual Meeting of the Associated Professional Sleep Societies in Baltimore; the Pituitary Society's Thirteenth International Pituitary Congress, in San Francisco; ENDO 2013, The Endocrine Society's 95th Annual Meeting & Expo, also in San Francisco; The American Association of Nurse Practitioners 28th National Conference in Las Vegas; The 2013 Summer Meeting of the American Academy of Dermatology in New York City; Obesity Week in Atlanta, Georgia; Lifestyle Medicine 2013 in Washington, D.C.; even the 9th World Congress of Cosmetic Dermatology held in Athens, Greece.

And it isn't just those involved with the world of clinical research that have become so interested in human growth hormone. It seems everyone's been talking about it; hGH has been featured on The Today Show, CNN, Fox News, The Dr. Oz Show, and in Vanity Fair and Shape, to name just a few. And SeroVital-hgh itself has already broken records in Parade magazine, been featured in Shape, on Radar Online and New York Live, and it's been touted by celebrity makeup artists. Even the United States Patent Office has added to the SeroVital explosion by issuing U.S. Pat. No. 8,551,542 protecting the SeroVital formula from imitators.

Why all the publicity? Because until recently, most felt the best way to increase our hGH levels was through expensive prescription injections (although costs can run as high as $1500 per month). However, some experts argue against the use of these synthetic injections, because they fear introducing synthetic hGH into the body may upset natural hGH production.

"That's what makes SeroVital so revolutionary," says Dr. Amy Heaton, PhD, Director of Scientific Affairs for SanMedica. "Rather than introducing synthetic hGH into the body like the injections do, SeroVital raises the body's own, natural levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. And the women's health experts I met with at the conference were excited to learn that SeroVital can not only provide the women in their care with a more affordable way to raise their hGH levels, but can offer a clinically validated way to achieve this naturally, without injections."

Although SanMedica is enjoying all the popular media attention it's received, the company was excited to get back to its research roots by taking SeroVital to the AMWA Annual Meeting. "We were thrilled to have the opportunity to share our research with the highly respected group of women's medical professionals who attended the meeting," says Dr. Heaton. "The research behind SeroVital is not only revolutionary because it proves there's an oral compound capable of increasing growth hormone levels naturally — without synthetic injections — but also because it was the first clinical trial of its kind to test a compound's growth hormone boosting effects not just on young males, but on both men and women across an appropriately wide age range. We think it's important to let women's health experts know just how well women responded to the SeroVital complex."

In addition to a study on SeroVital's ability to increase mean hGH levels by 682%, SanMedica also recently released studies analyzing its effects on endurance and sleep. "The results of our pilot study on endurance showed that after two weeks of daily supplementation with SeroVital, the study subjects' VO2max (the established measure of endurance) significantly increased.  This is an important result because it shows that certain positive benefits of synthetic hGH injections can be achieved with use of SeroVital alone," Dr. Heaton explains. "And the preliminary results of our pilot study investigating SeroVital's direct effects on parameters of sleep efficiency showed that in subjects taking SeroVital prior to bedtime for twenty consecutive days, both time to fall asleep and time awake in the night decreased exponentially. These results make sense because natural hGH levels are known to be highest in the first half of sleep and play an important role in our ability to reach deep stages of slow wave sleep — the stages that we are less able to attain as we age."

Despite all the research behind SeroVital-hgh, some skeptics are saying it sounds too good to be true. So is there a catch? Well, there are three. First, as with hGH injections, SeroVital is not a "magic bullet" but one part of a healthy lifestyle choice including a sensible diet and exercise regimen.

Second, for proper absorption, you have to take SeroVital on an empty stomach. That means you either have to take it first thing in the morning and then not eat anything for two hours, or take it at night, at least two hours after your last meal... before you go to bed.

And last but not least, while SeroVital is far less expensive than prescription hGH injections, it's still not cheap… SeroVital will cost you about $100 a month. But is it worth it? To most people, anything that may reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, strengthen bones, and boost mood, while giving you plenty of energy and improving sex drive, is a no-brainer. However, make no mistake about it, the "established" medical community (and of course they know everything) would say its benefits are largely anecdotal, and based on research that's preliminary. But there's no denying that something that has a chance of making you look and feel decades, not years, but DECADES younger, is... at the very least... irresistible.

For more information about The AMWA, visit www.amwa-doc.org. SeroVital is currently available at all Ulta stores. Over the next few months, it will be available on a limited basis at prestige retailers across the U.S. Can't wait? You can order it directly from SanMedica International by calling 1-800-591-8602 or visit their website at www.SeroVital.com. Use the promo code WOCON5 at checkout for free shipping.*

*Free standard shipping in the continental U.S. only.
All trademarks are the property of their individual owners.

SOURCE SeroVital

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.